[PDF][PDF] BM Aarts*, EG Klompenhouwer*, RC Dresen, A. Laenen, RGH Beets-Tan, K. Punie, P. Neven, H. Wildiers, G. Maleux
RC Dresen - … oncology in the management of breast and …, 2020 - cris.maastrichtuniversity.nl
Purpose: The aim of this study was to determine the safety and efficacy of Mitomycin C
(MMC) infusion in a large cohort of advanced liver metastatic breast cancer patients (LMBC) …
(MMC) infusion in a large cohort of advanced liver metastatic breast cancer patients (LMBC) …
[PDF][PDF] BM Aarts*, EG Klompenhouwer*, RC Dresen, CM Deroose, RGH Beets-Tan, K. Punie, P. Neven, H. Wildiers, G. Maleux
RGH Beets-Tan - … oncology in the management of breast …, 2020 - cris.maastrichtuniversity.nl
Purpose: The aim of the study was to evaluate the safety and feasibility of intra-arterial
Mitomycin C (MMC) infusion after selective internal radiation therapy (SIRT) using yttrium-90 …
Mitomycin C (MMC) infusion after selective internal radiation therapy (SIRT) using yttrium-90 …
Molecular Imaging in Management of Breast Cancer
PP Manapragada - Seminars in Roentgenology, 2018 - Elsevier
Background Breast density is one of the important risk factors for breast cancer. Women with
the highest breast density have a 4-to 6-fold increased risk compared with women with …
the highest breast density have a 4-to 6-fold increased risk compared with women with …
Endocrine Treatment Is Still the Main Option in the Management of Metastatic Breast Cancer Patients with Liver-Dominant Metastases.
K Altundağ - Journal of Vascular and Interventional Radiology: JVIR, 2016 - europepmc.org
Endocrine Treatment Is Still the Main Option in the Management of Metastatic Breast Cancer
Patients with Liver-Dominant Metastases. - Abstract - Europe PMC Sign in | Create an account …
Patients with Liver-Dominant Metastases. - Abstract - Europe PMC Sign in | Create an account …
[引用][C] Radioembolization for Primary and Metastatic Tumors of the Liver Policy#: 09.00. 48g
M NECESSARY - Policy